Methotrexate (MTX) is the widely agreed upon first-choice second-line agent to treat juvenile idiopathic arthritis (JIA), up to 75% of JIA patients in recent registries have used MTX at some time ...
After 24 weeks of treatment, patients in the chicken CII ... Furthermore, the dose of methotrexate used was low, and higher doses might have widened the efficacy gap between methotrexate and ...
This study reports on the adverse effect profile of methotrexate when used in the treatment of RA and PsA in a district general hospital population, and looks at the effect of alcohol consumption ...